Concepedia

Paul L. Hallenbeck

PL

25

Publications

3.2K

Citations

25

H-Index

1987

Active since

Affiliations

Research Institute for Genetic and Human Therapy(Current)

Novartis (United States)

Scripps Research Institute

National Institutes of Health

Baylor College of Medicine

Paul L. Hallenbeck is an author at Research Institute for Genetic and Human Therapy specializing in medicine, gene expression, and pathology.

Top concepts

Publications per year

1987–2013

25

Publications

25

H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes.

Michael S. Marks, Paul L. Hallenbeck, Toshi Nagata et al. · The EMBO Journal · 1992 · 474 citations · Full text

, , +12

Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus

Laura M. Hales, Nick J. Knowles, P. Seshidar Reddy et al. · Journal of General Virology · 2008 · 374 citations

A Novel Tumor-Specific Replication-Restricted Adenoviral Vector for Gene Therapy of Hepatocellular Carcinoma

Paul L. Hallenbeck, Doug Golightly, David A. Stewart et al. · Human Gene Therapy · 1999 · 283 citations

, , +16

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

P. Seshidhar Reddy, Kevin D. Burroughs, Laura M. Hales et al. · JNCI Journal of the National Cancer Institute · 2007 · 250 citations · Full text

Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.

Shuichi Kaneko, Paul L. Hallenbeck, Takenori Kotani et al. · PubMed · 1995 · 177 citations

, , +16

Rows per page

1–5 of 25